The increased TLR1/2, TLR2/6, and TLR4 expression may lead to exaggerated immune responses triggered by bacterial infection in HBV-related ACLF patients, and thus promotes the deterioration of liver disease. This evidence concerns the gene TLR1 and liver disorder.